Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 352 entries
View as:

Safety Study of Lifitegrast to Treat Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT01636206 Org: User:
Start: 10/16/12 End: 03/03/14 Due: 03/03/15

A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03888755 Org: User:
Start: 03/18/15 End: 02/12/16 Due: 02/12/17

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Phase: N/A Priority: Normal
NCT ID: NCT00172185 Org: User:
Start: 01/10/05 End: 01/24/08 Due: 01/24/09

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01081145 Org: User:
Start: 05/11/10 End: 06/03/13 Due: 06/03/14

Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01010750 Org: User:
Start: 01/05/10 End: 03/28/10 Due: 03/28/11

Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support

Phase: N/A Priority: Normal
NCT ID: NCT02980666 Org: User:
Start: 01/13/17 End: 01/21/20 Due: 01/21/21

Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00762073 Org: User:
Start: 01/08/09 End: 04/02/10 Due: 04/02/11

Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)

Phase: N/A Priority: Normal
NCT ID: NCT01509768 Org: User:
Start: 04/09/12 End: 10/10/13 Due: 10/10/14

Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT01343823 Org: User:
Start: 06/01/11 End: 06/01/12 Due: 06/01/13

Long-Term Safety Of PF-00547659 In Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01771809 Org: User:
Start: 03/18/13 End: 12/13/17 Due: 12/13/18

Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine

Phase: N/A Priority: Normal
NCT ID: NCT01418365 Org: User:
Start: 08/22/11 End: 10/05/11 Due: 10/05/12

Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00506727 Org: User:
Start: 08/05/03 End: 07/02/04 Due: 07/02/05

Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04460105 Org: User:
Start: 10/31/20 End: 01/27/21 Due: 01/27/22

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

Phase: N/A Priority: Normal
NCT ID: NCT00905424 Org: User:
Start: 07/30/09 End: 08/04/10 Due: 08/04/11

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01130844 Org: User:
Start: 10/08/10 End: 06/27/13 Due: 06/27/14

Safety and Efficacy of SPD465 in Adults With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00202605 Org: User:
Start: 09/29/05 End: 01/06/06 Due: 01/06/07

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

Phase: N/A Priority: Normal
NCT ID: NCT04583007 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00548574 Org: User:
Start: 12/04/03 End: 10/20/04 Due: 10/20/05

Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.

Phase: N/A Priority: Normal
NCT ID: NCT00152022 Org: User:
Start: 04/25/05 End: 11/04/05 Due: 11/04/06

An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.

Phase: N/A Priority: Normal
NCT ID: NCT02350816 Org: User:
Start: 04/08/15 End: 04/12/19 Due: 04/12/20

Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01101022 Org: User:
Start: 05/19/10 End: 11/29/10 Due: 11/29/11

Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)

Phase: N/A Priority: Normal
NCT ID: NCT03627091 Org: User:
Start: 02/06/19 End: 09/13/21 Due: 09/13/22

Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02009163 Org: User:
Start: 01/27/14 End: 04/08/15 Due: 04/08/16

Safety of SPD465 in Treating Adults With ADHD.

Phase: N/A Priority: Normal
NCT ID: NCT00152035 Org: User:
Start: 03/10/05 End: 11/07/06 Due: 11/07/07

A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.

Phase: N/A Priority: Normal
NCT ID: NCT00150540 Org: User:
Start: 10/14/02 End: 06/29/05 Due: 06/29/06